Read the latest report from the Pharmaceutical Research and Manufacturers of America (PhRMA) about new medicines that are currently being tested or awaiting approval from the Food and Drug Administration.  This article is published by Long Term Living.

The new medicines include 150 for diabetes, which affects 12.2 million Americans age 60 and older; 62 for eye disorders that contribute significantly to late-life disability; and 91 for Alzheimer’s disease, which could afflict 16 million people by 2050 without further advances in treatment. Other medicines target depression, osteoporosis, Parkinson’s disease, prostate disease, bladder and kidney diseases, and other debilitating conditions.

Click here for more information on this report: